165 related articles for article (PubMed ID: 11247771)
21. Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction.
Carlson DL; Willis MS; White DJ; Horton JW; Giroir BP
Crit Care Med; 2005 May; 33(5):1021-8. PubMed ID: 15891331
[TBL] [Abstract][Full Text] [Related]
22. Caspase inhibition protects from liver injury following ischemia and reperfusion in rats.
Cursio R; Gugenheim J; Ricci JE; Crenesse D; Rostagno P; Maulon L; Saint-Paul MC; Ferrua B; Mouiel J; Auberger P
Transpl Int; 2000; 13 Suppl 1():S568-72. PubMed ID: 11112076
[TBL] [Abstract][Full Text] [Related]
23. Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction.
Radhakrishnan J; Ayoub IM; Gazmuri RJ
Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1164-74. PubMed ID: 19234092
[TBL] [Abstract][Full Text] [Related]
24. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo.
Holly TA; Drincic A; Byun Y; Nakamura S; Harris K; Klocke FJ; Cryns VL
J Mol Cell Cardiol; 1999 Sep; 31(9):1709-15. PubMed ID: 10471354
[TBL] [Abstract][Full Text] [Related]
25. Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2.
Guo H; Tittle TV; Allen H; Maziarz RT
Exp Cell Res; 1998 Nov; 245(1):57-68. PubMed ID: 9828101
[TBL] [Abstract][Full Text] [Related]
26. Antiapoptotic effect of benzyloxycarbonyl-aspartyl-(beta-tertier-butyl ester)-bromomethylketone (Z-D(OtBu)-Bmk), an intermediate of interleukin-1 beta converting enzyme inhibitors.
Németh K; Bugovics G; Székely JI
Int J Immunopharmacol; 1997 Apr; 19(4):215-25. PubMed ID: 9373772
[TBL] [Abstract][Full Text] [Related]
27. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.
Slee EA; Zhu H; Chow SC; MacFarlane M; Nicholson DW; Cohen GM
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):21-4. PubMed ID: 8670109
[TBL] [Abstract][Full Text] [Related]
28. Multiple intracellular pathways interfere with the activation of a CPP32-like protease induced by serum deprivation of AKR-2B cells.
Schäfer R; Karbach D; Hoppe J
Exp Cell Res; 1998 Apr; 240(1):28-39. PubMed ID: 9570918
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.
Endres M; Namura S; Shimizu-Sasamata M; Waeber C; Zhang L; Gómez-Isla T; Hyman BT; Moskowitz MA
J Cereb Blood Flow Metab; 1998 Mar; 18(3):238-47. PubMed ID: 9498840
[TBL] [Abstract][Full Text] [Related]
30. RGD peptide-induced apoptosis in human leukemia HL-60 cells requires caspase-3 activation.
Anuradha CD; Kanno S; Hirano S
Cell Biol Toxicol; 2000; 16(5):275-83. PubMed ID: 11201051
[TBL] [Abstract][Full Text] [Related]
31. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases.
Shimizu T; Pommier Y
Leukemia; 1997 Aug; 11(8):1238-44. PubMed ID: 9264376
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor.
Yaoita H; Ogawa K; Maehara K; Maruyama Y
Circulation; 1998 Jan; 97(3):276-81. PubMed ID: 9462530
[TBL] [Abstract][Full Text] [Related]
33. Suppression of human T cell proliferation by the caspase inhibitors, z-VAD-FMK and z-IETD-FMK is independent of their caspase inhibition properties.
Lawrence CP; Chow SC
Toxicol Appl Pharmacol; 2012 Nov; 265(1):103-12. PubMed ID: 22982538
[TBL] [Abstract][Full Text] [Related]
34. Non-specific effects of methyl ketone peptide inhibitors of caspases.
Schotte P; Declercq W; Van Huffel S; Vandenabeele P; Beyaert R
FEBS Lett; 1999 Jan; 442(1):117-21. PubMed ID: 9923616
[TBL] [Abstract][Full Text] [Related]
35. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis.
Vantieghem A; Assefa Z; Vandenabeele P; Declercq W; Courtois S; Vandenheede JR; Merlevede W; de Witte P; Agostinis P
FEBS Lett; 1998 Nov; 440(1-2):19-24. PubMed ID: 9862416
[TBL] [Abstract][Full Text] [Related]
36. Caspase inhibitors promote the survival of avulsed spinal motoneurons in neonatal rats.
Chan YM; Wu W; Yip HK; So KF; Oppenheim RW
Neuroreport; 2001 Mar; 12(3):541-5. PubMed ID: 11234760
[TBL] [Abstract][Full Text] [Related]
37. Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation.
Matsura T; Kai M; Fujii Y; Ito H; Yamada K
Free Radic Res; 1999 Jan; 30(1):73-83. PubMed ID: 10193575
[TBL] [Abstract][Full Text] [Related]
38. Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3.
Miyashita T; Nagao K; Krajewski S; Salvesen GS; Reed JC; Inoue T; Yamada M
Cell Death Differ; 1998 Dec; 5(12):1034-41. PubMed ID: 9894610
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells.
Denmeade SR; Lin XS; Tombal B; Isaacs JT
Prostate; 1999 Jun; 39(4):269-79. PubMed ID: 10344216
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of apoptosis by caspase inhibitor Z-VAD-FMK improves cryotolerance of in vitro derived bovine embryos.
Pero ME; Zullo G; Esposito L; Iannuzzi A; Lombardi P; De Canditiis C; Neglia G; Gasparrini B
Theriogenology; 2018 Mar; 108():127-135. PubMed ID: 29207293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
